omniture
logo
Search
InventisBio
Media Room

Latest News

rss

InventisBio Reported Promising Phase I Study Results of a Novel KRAS G12C Inhibitor D-1553 in Cancer Patients

SHANGHAI, April 11, 2022 /PRNewswire/ -- InventisBio Co., Ltd., a clinical-stage biotech company ba...

2022-04-11 17:37 463

InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures

SHANGHAI, Sept. 28, 2020 /PRNewswire/ -- InventisBio, a clinical stage biotech company dedicated to...

2020-09-28 05:00 3836